Menu
Back to User profile » Dr Brett Hauber
Papers published by Dr Brett Hauber:
The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer
Hauber B, Penrod JR, Gebben D, Musallam L
Patient Preference and Adherence 2020, 14:2093-2104
Published Date: 30 October 2020
Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
Graham-Clarke PL, Hauber B, Boeri M, Leonardi F, Burge RT, Fernandez M, Tockhorn-Heidenreich A, Florez S
Patient Preference and Adherence 2020, 14:1049-1064
Published Date: 23 June 2020
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
Boeri M, Szegvari B, Hauber B, Mange B, Mountian I, Schiff M, Maniadakis N
Patient Preference and Adherence 2019, 13:1093-1110
Published Date: 11 July 2019
Patient and physician preferences for ulcerative colitis treatments in the United States
Boeri M, Myers K, Ervin C, Marren A, DiBonaventura M, Cappelleri JC, Hauber B, Rubin DT
Clinical and Experimental Gastroenterology 2019, 12:263-278
Published Date: 11 June 2019
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, Grothey A
Cancer Management and Research 2017, 9:149-158
Published Date: 27 April 2017
Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials
Katz EG, Hauber B, Gopal S, Fairchild A, Pugh A, Weinstein RB, Levitan BS
Patient Preference and Adherence 2016, 10:2127-2139
Published Date: 21 October 2016
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, Brodovicz K, Alexander CM, Davies M, Iglay K, Zhang Q, Radican L
Patient Preference and Adherence 2013, 7:937-949
Published Date: 18 September 2013
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
Hauber AB, Gonzalez JM, Coombs J, Sirulnik A, Palacios D, Scherzer NJ
Patient Preference and Adherence 2011, 5:307-314
Published Date: 24 June 2011